Author:
Wernli Karen J.,Newcomb Polly A.,Hampton John M.,Trentham-Dietz Amy,Egan Kathleen M.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Hersh AL, Stefanick ML, Stafford RS (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291:47–53
2. Writing Group for the Women’s Health Initiative I (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the women’s health initiative randomized controlled trial. JAMA 288:321–333
3. Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F (2005) Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncology 6:552–553
4. Cook LS, Weiss NS, Doherty JA, Chen C (2006) Endometrial cancer. In: Schottenfeld D, Fraumeni JF (eds), Cancer epidemiology and prevention. Oxford, Oxford Press
5. Danforth KN, Tworoger SS, Hecht JL, Rosner BA, Colditz GA, Hankinson SE (2007) A prospective study of postmenopausal hormone use and ovarian cancer risk. Br J Cancer 96:151–156
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献